Landsberg Bennett & Dubbaneh’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-28,492
Closed -$1.5M 291
2021
Q2
$1.5M Sell
28,492
-12,776
-31% -$667K 0.2% 113
2021
Q1
$2.04M Sell
41,268
-761
-2% -$36.6K 0.29% 89
2020
Q4
$2.04M Buy
42,029
+1,213
+3% +$59.8K 0.31% 86
2020
Q3
$2.06M Buy
40,816
+24,006
+143% +$1.24M 0.36% 79
2020
Q2
$859K Buy
+16,810
New +$817K 0.18% 104

Other funds holding SNY

Landsberg Bennett & Dubbaneh's SNY Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh sold out of Sanofi (SNY) in Q3 2021, closing a stake of 28,492 shares — an estimated $1.5M sold.

Landsberg Bennett & Dubbaneh first reported a position in SNY in Q2 2020 and held it in 5 quarters. The position peaked at $2.06M in Q3 2020. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

  • Landsberg Bennett & Dubbaneh reported no remaining Sanofi position as of Q3 2021 after selling out during the quarter.
  • Landsberg Bennett & Dubbaneh sold 28,492 Sanofi shares in Q3 2021, an estimated $1.5M.
  • Landsberg Bennett & Dubbaneh first reported a position in Sanofi in Q2 2020 and held it in 5 quarters.
  • Landsberg Bennett & Dubbaneh's Sanofi position peaked at $2.06M in Q3 2020.
  • 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.